SCHEMBL9890211

SCHEMBL9890211

c1ccc(-n2c3ccc(-n4c5ccccc5c5ccccc54)cc3c3cc4sc5ccc(-n6c7ccccc7c7ccccc76)cc5c4cc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
KDM4E B2RXH2 1/20 0.51
HSD17B10 Q99714 1/20 0.36
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
GAA P10253 1/20 0.33
PTPN1 P18031 2/20 0.33
GPR3 P46089 1/20 0.32
HDAC4 P56524 1/20 0.32
MAPK8 P45983 2/20 0.32
IL1R1 P14778 1/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDR P35968 1/20 0.32
MAPK9 P45984 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246309 0.96 ATM (0.50) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL9890457 0.94 ATM (0.51) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL19342694 0.94 ATM (0.51) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL27428458 0.94 ATM (0.51) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL15462290 0.93 ATM (0.53) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL15946318 0.91 ATM (0.55) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL26809957 0.91 GPR3 (0.42) ATML3MBTL1KDM4EHSD17B10ALDH1A1
SCHEMBL17246303 0.91 GPR3 (0.42) ATML3MBTL1KDM4EHSD17B10ALDH1A1
SCHEMBL18254316 0.90 ATM (0.50) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL21481652 0.90 L3MBTL1 (0.50) ATML3MBTL1KDM4EHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 ATM 3103/4885L3MBTL1 709/4885KDM4E 990/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 ATM 3103/4885L3MBTL1 709/4885KDM4E 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.